Mavis S. Fletcher
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Immunology and Allergy top 2%
- Co-authors
- Anil K. SoodMary J.C. HendrixLynn M. GrumanCharles N. LandenJeremy E. CoffinDavid M. GershensonLiz Y. HanAparna A. Kamat
- Topics
- Angiogenesis and VEGF in Cancer (6 papers)Ovarian cancer diagnosis and treatment (4 papers)Axon Guidance and Neuronal Signaling (4 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Mavis S. Fletcher
19 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 891
- Oncology 534
- Cancer Research 531
- Immunology 251
- Immunology and Allergy 243
Countries citing papers authored by Mavis S. Fletcher
This map shows the geographic impact of Mavis S. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mavis S. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mavis S. Fletcher more than expected).
Fields of papers citing papers by Mavis S. Fletcher
This network shows the impact of papers produced by Mavis S. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mavis S. Fletcher. The network helps show where Mavis S. Fletcher may publish in the future.
Co-authorship network of co-authors of Mavis S. Fletcher
This figure shows the co-authorship network connecting the top 25 collaborators of Mavis S. Fletcher. A scholar is included among the top collaborators of Mavis S. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mavis S. Fletcher. Mavis S. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 195 | |
| 5 | 124 | |
| 6 | 14 | |
| 7 | 91 | |
| 8 | 19 | |
| 9 | 143 | |
| 10 | 16 | |
| 11 | 15 | |
| 12 | 87 | |
| 13 | 214 | |
| 14 | 171 | |
| 15 | 13 | |
| 16 | 77 | |
| 17 | The paradoxical expression of maspin in ovarian carcinoma. | 162 |
| 18 | 218 | |
| 19 | 8 | |
| 20 | Fine-Needle Aspiration and Histologic Findings | 1 |
About Mavis S. Fletcher
Mavis S. Fletcher is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Axon Guidance and Neuronal Signaling (4 papers). The work is most often cited by research in Immunology and Allergy (243 citations), Cancer Research (531 citations) and Reproductive Medicine (210 citations). Mavis S. Fletcher has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Anil K. Sood, Mary J.C. Hendrix, Lynn M. Gruman, Charles N. Landen, Jeremy E. Coffin, David M. Gershenson, Liz Y. Han, Aparna A. Kamat, Elisabeth A. Seftor and Michael T. Deavers. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.